Page last updated: 2024-08-16
ro 31-8220 and mdv 3100
ro 31-8220 has been researched along with mdv 3100 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Imada, K; Inokuchi, J; Kashiwagi, E; Naito, S; Shiota, M; Song, Y; Takeuchi, A; Tatsugami, K; Uchiumi, T; Yokomizo, A | 1 |
Other Studies
1 other study(ies) available for ro 31-8220 and mdv 3100
| Article | Year |
|---|---|
Inhibition of protein kinase C/Twist1 signaling augments anticancer effects of androgen deprivation and enzalutamide in prostate cancer.
Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Humans; Indoles; Male; Nitriles; Nuclear Proteins; Phenylthiohydantoin; Phosphorylation; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Protein Kinase C; Protein Processing, Post-Translational; Receptors, Androgen; Signal Transduction; Twist-Related Protein 1 | 2014 |